Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Gastrointestinal 5Thoracic 3Genitourinary 3Other hematologic neoplasm 2Other 2Dermatologic 2Plasma cell 1

Conditions

Multiple Myeloma 420Lymphoma 53Recurrence 42Neoplasms, Plasma Cell 33Hematologic Neoplasms 33Immunoglobulin Light-chain Amyloidosis 29Smoldering Multiple Myeloma 26Lymphoma, Non-Hodgkin 25Leukemia, Myeloid, Acute 20Leukemia, Lymphocytic, Chronic, B-Cell 20Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Hodgkin Disease 17Myelodysplastic Syndromes 16Monoclonal Gammopathy of Undetermined Significance 13Waldenstrom Macroglobulinemia 11Lymphoma, Mantle-Cell 11Leukemia 11Prostatic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Breast Neoplasms 10Paraproteinemias 9Ovarian Neoplasms 9Lung Neoplasms 8Leukemia, Plasma Cell 8Amyloidosis 8Melanoma 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fatigue × Plasma cell × 90 days × Clear all
NCT07102212 2026-05-18

FOCUS

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
120 enrolled
BreastDermatologicGenitourinaryPlasma cellThoracic

Alzheimer Disease, Anxiety Disorders, Breast Neoplasms, Depression, Fatigue, Lung Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡